Eva Anette Engelhardt sold $136k of BIO
EVP, President, CDG at BIO-RAD LABORATORIES, INC.. 550 shares at an average of $246.54, traded May 11, 2026, filed May 13, 2026.
Score components
- +15RoleOfficer
- +11Trade size$136k at market
- +20Share of holdings soldSold 61% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +17.4%, 3m +48.7%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002024911-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 11, 2026 | SOpen-market sale Bio-Rad A Common Stock | -550 | $246.54 | $136k | 346 | May 13, 2026 |
Related signals
Other insiders at BIO-RAD LABORATORIES, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | BIOsell BIO-RAD LABORATORIES, INC. | James Barry EVP, President, LSG | $214k 700 shares | -58% | |
| 31Weak | BIOsell BIO-RAD LABORATORIES, INC. | Michael Crowley EVP, GBL Commercial Operations | $741k 3,000 shares | -27% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.